Uptake of a colorectal cancer screening blood test is higher than of a fecal test offered in clinic

Posted on March 06 2017 by J Seabrook

Results of the study with the blood test Epi proColon® is now published in the journal of “Cancer Treatment and Research Communications”. Read more


MPLN and Geneuity Twitter News Feed

Posted on February 21 2017 by J Seabrook

You can view MPLN's Twitter Feed by clicking here @molpathnet

Molecular Pathology Laboratory Network, custom services for #oncologists #pathologists;
experience in #flowcytometry…
Read more

Laboratory Developed Tests Roadmap and IVD Vendors

Posted on December 13 2016 by J Seabrook

MPLN follows a development process for laboratory developed tests. A phased approach is useful for organizing and assessing the performance of an assay. 

Read more


Concordance of three different PD-L1 diagnostic tests - update

Posted on December 07 2016 by J Seabrook

Concordance of three different PD-L1 diagnostic assays (1)

MPLN’s PD-L1 assay, the Ventana SP263, was included in the concordance study of three PD-L1 Diagnostic Tests by AstraZeneca and results reported at Read more

CAP Today Reports on Epi proColon Assay for Colon Cancer Screening

Posted on December 06 2016 by J Seabrook

A recent article by Anne Paxton in CAP Today (November 2016)  discusses the FDA approval of the Epigenomics Epi proColon® assay for colon cancer screening. MPLN's Dr. Nicholas Potter explains the series of events and the study data from…
Read more

1 2 3 4 5 6 7